BioSpace News Archive

Deals

Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Axsome Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 2,300,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase additional shares, at the public offering price of $87.00 per share.

December 23, 2019
·
4 min read
BioCapital

Leidos, Intel, and First Genesis Earn ACT-IAC Blockchain Innovations Award

Leidos, Intel Corporation, and First Genesis announced their collaborative approach in developing blockchain technologies to improve healthcare has earned the American Council for Technology and Industry Advisory Council’s 2019 Audience Choice Award.

December 23, 2019
·
4 min read
Deals

Bioasis Completes Bridge Financing Transaction

This News Release Is Intended for Distribution in Canada Only and Is Not Intended for Distribution to United States Newswire Services or Dissemination in the United States

December 23, 2019
·
6 min read
Business

Advanced Gynecology Buckhead - The Most Innovative Medical Practice Gets a New Addition in the Heart of Buckhead

Advanced Gynecology is eager to serve the greater Atlanta community - now including Buckhead - with the best possible urogynecological care and top board-certified physicians.

December 23, 2019
·
2 min read
Policy

Teligent, Inc. Announces FDA Request for Further Data on Complex Drug

Teligent, Inc. announced its development partner has received a Complete Response Letter from the U.S. Food and Drug Administration for its abbreviated new drug application for its first complex drug indicated for an orphan disease population.

December 23, 2019
·
2 min read
Policy

Advisory - One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age

Health Canada is advising Canadians, particularly parents and caregivers, that Taro Pharmaceuticals Inc. is recalling one lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream because of a labelling error that may pose serious health risks to children under two years of age..

December 23, 2019
·
2 min read
Biotech Beach

Illumina to Webcast Upcoming Investor Conference Presentation in January 13, 2020

Illumina, Inc. announced that its executives will be speaking at the following investor conference and invite investors to participate via webcast.

December 23, 2019
·
1 min read
Biotech Beach

Good Samaritan Hospital Joins PIH Health Network

California Attorney General Approves PIH Health’s Member Substitution of Good Samaritan Hospital, Los Angeles

December 23, 2019
·
4 min read
Drug Development

Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre

Expects to report Trilogy 1 topline results in January 2020 with topline results for Trilogy 2 still expected by the end of January 2020

December 23, 2019
·
7 min read
Business

Roche and Sarepta Partner on Duchenne Muscular Dystrophy Therapy

Sarepta Therapeutics and Roche inked a licensing deal that gives Roche exclusive commercial rights to SRP-9001, Sarepta’s investigation gene therapy for Duchenne muscular dystrophy, outside the U.S.

December 23, 2019
·
2 min read
·
Mark Terry